The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Vaxcyte Inc (NASDAQ: PCVX) closed at $31.85 in the last session, up 3.07% from day before closing price of $30.90. In other words, the price has increased by $3.07 from its previous closing price. On the day, 1.51 million shares were traded.
Ratios:
We take a closer look at PCVX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.70 and its Current Ratio is at 17.70. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 20, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $135.
On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.Mizuho initiated its Buy rating on December 07, 2023, with a $69 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Stock Price History:
Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is -29.10%, while the 200-Day Moving Average is calculated to be -60.83%.
Shares Statistics:
A total of 128.94M shares are outstanding, with a floating share count of 125.07M. Insiders hold about 2.92% of the company’s shares, while institutions hold 113.81% stake in the company.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 5.0 analysts currently analyzing and rating the stock of Vaxcyte Inc (PCVX).The consensus estimate for the next quarter is -$1.21, with high estimates of -$1.04 and low estimates of -$1.32.
Analysts are recommending an EPS of between -$4.11 and -$5.09 for the fiscal current year, implying an average EPS of -$4.69. EPS for the following year is -$5.21, with 5.0 analysts recommending between -$4.04 and -$5.68.
